ArticleLeukemia research reports2021

Promising remissions in relapsed refractory classical Hodgkin lymphoma patients requiring multiple salvage regimens before transplantation in the brentuximab vedotin era.

Khadega A Abuelgasim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.